August 22, 2017 / 8:42 AM / 4 months ago

BRIEF-Zhejiang Huahai Pharmaceutical passes U.S. FDA approval

Aug 22(Reuters) - Zhejiang Huahai Pharmaceutical Co Ltd :

* Says it received FDA approval for Paroxetine Capsules from U.S Food and Drug Administration

* Paroxetine Capsules is used for treatment of Vasomotor Symptoms

* Company will be able to sell its Paroxetine Capsules in the United States after receiving the FDA approval

Source text in Chinese: goo.gl/umKNRK

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below